注意事项
抗生素
多路复用
周转时间
检测点注意事项
临床微生物学
微生物培养
抗菌管理
抗生素耐药性
计算生物学
生物
医学
微生物学
细菌
计算机科学
生物信息学
免疫学
病理
操作系统
遗传学
作者
Yiyan Li,Xing Yang,Weian Zhao
出处
期刊:
[Elsevier BV]
日期:2017-08-29
卷期号:22 (6): 585-608
被引量:92
标识
DOI:10.1177/2472630317727519
摘要
Rapid bacterial identification (ID) and antibiotic susceptibility testing (AST) are in great demand due to the rise of drug-resistant bacteria. Conventional culture-based AST methods suffer from a long turnaround time. By necessity, physicians often have to treat patients empirically with antibiotics, which has led to an inappropriate use of antibiotics, an elevated mortality rate and healthcare costs, and antibiotic resistance. Recent advances in miniaturization and automation provide promising solutions for rapid bacterial ID/AST profiling, which will potentially make a significant impact in the clinical management of infectious diseases and antibiotic stewardship in the coming years. In this review, we summarize and analyze representative emerging micro- and nanotechnologies, as well as automated systems for bacterial ID/AST, including both phenotypic (e.g., microfluidic-based bacterial culture, and digital imaging of single cells) and molecular (e.g., multiplex PCR, hybridization probes, nanoparticles, synthetic biology tools, mass spectrometry, and sequencing technologies) methods. We also discuss representative point-of-care (POC) systems that integrate sample processing, fluid handling, and detection for rapid bacterial ID/AST. Finally, we highlight major remaining challenges and discuss potential future endeavors toward improving clinical outcomes with rapid bacterial ID/AST technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI